Pilar I Beato-Vibora
Overview
Explore the profile of Pilar I Beato-Vibora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quiros C, Herrera Arranz M, Amigo J, Wagner A, Beato-Vibora P, Azriel-Mira S, et al.
Diabetes Technol Ther
. 2024 Feb;
26(8):596-606.
PMID: 38417014
To compare glycemic control and maternal-fetal outcomes of women with type 1 diabetes (T1D) using hybrid closed loop (HCL) versus multiple daily insulin injections (MDI) plus continuous glucose monitoring. Multicenter...
2.
Beato-Vibora P, Gallego-Gamero F, Ambrojo-Lopez A
Nutr Metab Cardiovasc Dis
. 2021 Apr;
31(6):1845-1850.
PMID: 33838993
Background And Aims: Several treatment modalities are available for type 1 diabetes (T1D), including continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) with MDI, sensor-augmented pumps with predictive low-glucose...
3.
Beato-Vibora P, Lazaro-Martin L, Gallego-Gamero F, Ambrojo-Lopez A
J Diabetes Sci Technol
. 2021 Feb;
16(4):934-938.
PMID: 33596681
Background And Aims: The use of continuous glucose monitoring (CGM) has become standard practice in people with type 1 diabetes. The evaluation of user satisfaction is crucial. The Glucose Monitoring...
4.
Beato-Vibora P, Arroyo-Diez F
Drugs Context
. 2019 Aug;
8:212599.
PMID: 31402931
Hypoglycaemia is the more frequent complication of insulin therapy and the main barrier to tight glycaemic control. Injectable glucagon and oral intake of carbohydrates are the recommended treatments for severe...
5.
Beato-Vibora P, Arroyo-Diez F
Acta Diabetol
. 2018 Jul;
55(10):1083-1085.
PMID: 29987593
No abstract available.
6.
Beato-Vibora P, Alejo-Gonzalez S
Int J Endocrinol Metab
. 2017 Aug;
15(1):e37792.
PMID: 28835757
Introduction: Interfering antibodies are capable of causing potentially misleading results in automated thyroid hormone immunoassays. Case Presentation: We report the case of a 46- year-old female patient with autoimmune hypothyroidism...
7.
Beato-Vibora P, Arroyo-Diez F
Diabetes Technol Ther
. 2013 Oct;
16(2):123-4.
PMID: 24160691
No abstract available.